Balchem(US:BCPC) Globenewswire·2025-04-24 11:00Core Insights - Balchem Corporation reported strong financial results for the first quarter of 2025, with record net sales and adjusted EBITDA, indicating growth across all business segments [1][2][4]. Financial Performance - Net sales reached $250.5 million, an increase of $10.9 million or 4.5% compared to the same quarter last year [7]. - Net earnings were $37.1 million, reflecting a 27.8% increase year-over-year [7]. - Adjusted EBITDA was $66.3 million, up 8.9% from the prior year [7]. - Free cash flow for the quarter was $31.0 million, with cash flows from operations at $36.5 million [7][14]. Segment Performance - The Human Nutrition and Health segment generated record sales of $158.5 million, a 3.7% increase, with earnings from operations rising 14.2% to $38.0 million [9]. - The Animal Nutrition and Health segment reported sales of $57.3 million, a 6.2% increase, with earnings from operations soaring 154.2% to $5.2 million [10]. - The Specialty Products segment achieved sales of $33.3 million, a 5.3% increase, with earnings from operations increasing 16.9% to $9.6 million [11]. Operational Highlights - The company launched a new corporate website aimed at enhancing user experience and providing detailed product information [7]. - Balchem released its 2024 Sustainability Report, showcasing its commitment to sustainability and innovative solutions for global health and nutrition [7]. Balance Sheet and Cash Flow - As of March 31, 2025, total assets were $1.617 billion, with cash and cash equivalents at $49.9 million [20][21]. - Current liabilities decreased to $139.6 million from $157.7 million year-over-year [20]. Management Commentary - The CEO expressed confidence in the company's growth outlook despite global trade uncertainties, emphasizing the strength of the business model [4][15].